viernes, 14 de agosto de 2020

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study | BMC Cancer | Full Text

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study | BMC Cancer | Full Text

Medulloblastoma is extremely rare in adults. The role of chemotherapy for average-risk adult patients remains controversial. Surgery and radiotherapy provide a significant disease control and a good prognosis,...
Authors:E. Franceschi, S. Minichillo, A. Mura, A. Tosoni, M. Mascarin, C. Tomasello, S. Bartolini and A. A. Brandes
Citation:BMC Cancer 2020 20:755
Content type:Research article
 
Published on: 

No hay comentarios:

Publicar un comentario